FiercePharma says: The good news: Pfizer delivered a big increase in third-quarter profits; 26 percent, to be exact. The bad: revenues slipped 3 percent, highlighting the fact that cost-cutting boosted earnings, not product performance. (Nonetheless, sales did beat analyst estimates.) Read more of our coverage here... [2]
Highlights:
Check out Pfizer's current earnings estimates from CNN Money [3]
Pfizer's Website http://www.pfizer.com/home/ [4]
Related Articles:
Pfizer/Wyeth merger could eliminate $3B, R&D jobs [5]
Pfizer plans dramatic increase in new cancer drugs [6]
Generics expected to hit Merck, Pfizer earnings [7]
Pfizer moves to cap retiree health benefits [8]
Links:
[1] http://www.fiercebiotech.com/press-releases/pfizer-reports-third-quarter-2009-results
[2] http://www.fiercepharma.com/story/pfizer-sales-suffer-cost-cutting-delivers/2009-10-20
[3] http://money.cnn.com/quote/estimates/estimates.html?symb=PFE
[4] http://www.pfizer.com/home/
[5] http://www.fiercebiotech.com/story/pfizer-wyeth-merger-could-eliminate-3b-r-d/2009-10-15
[6] http://www.fiercebiotech.com/story/pfizer-plans-dramatic-increase-new-cancer-drugs/2009-07-14
[7] http://www.fiercepharma.com/story/generics-expected-hit-merck-pfizer-earnings/2009-10-16
[8] http://www.fiercepharma.com/story/pfizer-moves-cap-retiree-health-benefits/2009-09-22
[9] http://www.fiercepharma.com/special-reports/q3-top-pharma-company-earnings-reports
[10] http://www.fiercepharma.com/special-reports/glaxosmithkline-q3-results-q3-top-pharma-company-earnings-reports